{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:18:17Z","timestamp":1790367497039,"version":"4.1.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":128,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013226","name":"Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013226","name":"Les Laboratories Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Immune checkpoint inhibitors (ICIs) have significantly improved the overall survival of patients with metastatic melanoma. It is unclear how the growing group of metastatic melanoma survivors resume their lives after treatment, and which needs they have regarding survivorship care (SSC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To gain an in-depth understanding of metastatic melanoma survivors\u2019 experiences of resuming life after ICIs and their associated SSC needs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A qualitative study was conducted among 20 patients with metastatic melanoma in whom ICIs had been discontinued after ongoing tumour response. One focus group (n = 9) was held, which was complemented by 11 individual interviews. Purposive sampling was used to select a variable sample in terms of sex, age, time since discontinuation of ICIs, and perceived impact of the disease. A topic guide was used to structure the (group) interviews, which were transcribed verbatim and analysed in a thematic content analysis, using several phases of coding.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In resuming life after ICIs, the prognosis switch often caused mixed feelings among patients, mainly because of the uncertainty about the future. Demands and expectations from self and others, persistent complaints and new problems in different life domains often make it challenging to proceed with life as it was prior to metastatic cancer. Patients indicated they needed to find a new balance, which included learning to cope with uncertainty and a changed perspective on life and close relationships. In terms of SSC needs, patients particularly stressed the need for more tailored patient information, available at one location. In addition, they emphasized the need to know who to turn to in case of questions and indicated the need for psychosocial support, also for their close relatives.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Metastatic melanoma survivors face various challenges in resuming life after ICIs and are left with several unmet SSC needs. Efforts should be focused on offering psychosocial supportive care in addition to medical care, from diagnosis onwards, taking into account the patient\u2019s close relatives. A single point of contact and personalized survivorship care plan (SCP) could be of added value in guiding them through the patient journey, which is, given its multidisciplinary nature, particularly important in melanoma care.<\/jats:p>\n                  <jats:p>What is already known about this topic? Since the introduction of immune checkpoint inhibitors (ICIs) the overall survival of patients with metastatic melanoma has improved significantly, leading to a growing group of melanoma survivors. Melanoma survivors may face various problems and challenges in resuming life after treatment, which may be associated with unmet survivorship care (SSC) needs. An in-depth understanding of their experiences with resuming life and the associated SSC needs is currently lacking.<\/jats:p>\n                  <jats:p>What does this study add? Metastatic melanoma survivors experience various challenges after immunotherapy, from the uncertain prognosis switch to the struggle of finding a new balance in life. Besides negative aspects, such as complaints in different life domains, the patient journey is often accompanied by positive outcomes, for example a changed perspective on life. They stress the need for tailored patient information and broader supportive care, also for their close relatives.<\/jats:p>\n                  <jats:p>What are the clinical implications of this work? In addition to medical care, efforts should be focused on offering psychosocial supportive care, including return-to-work issues, from diagnosis onwards, ideally taking into account the patient\u2019s close relatives. To guide them through the patient journey, a single point of contact and a personalized survivorship care plan (SCP) could be of added value. The latter is particularly important in melanoma care, given its multidisciplinary nature.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/bjd.21670","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T12:44:31Z","timestamp":1653137071000},"page":"381-391","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma"],"prefix":"10.1093","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8386-2540","authenticated-orcid":false,"given":"Nadia C.W.","family":"Kamminga","sequence":"first","affiliation":[{"name":"Department of Dermatology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0446-1907","authenticated-orcid":false,"given":"Astrid A.M.","family":"van der Veldt","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot C.W.","family":"Joosen","sequence":"additional","affiliation":[{"name":"Department Tranzo, Tilburg School of Social and Behavioral Sciences Tilburg University Tilburg the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlijn","family":"de Joode","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen","family":"Joosse","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Radiology & Nuclear Medicine, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8293-6002","authenticated-orcid":false,"given":"Dirk J.","family":"Gr\u00fcnhagen","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9940-2875","authenticated-orcid":false,"given":"Tamar E.C.","family":"Nijsten","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8578-901X","authenticated-orcid":false,"given":"Marlies","family":"Wakkee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4117-2154","authenticated-orcid":false,"given":"Marjolein","family":"Lugtenberg","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands"},{"name":"Department Tranzo, Tilburg School of Social and Behavioral Sciences Tilburg University Tilburg the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"key":"2023010808101333500_bjd21670-bib-0001","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"2023010808101333500_bjd21670-bib-0002","first-page":"D2420","article-title":"Recent treatment results for metastatic melanoma: data from the Dutch Melanoma Treatment Registry","volume":"162","author":"Zeijl","year":"2018","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2023010808101333500_bjd21670-bib-0003","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001","volume":"30","author":"Hamid","year":"2019","journal-title":"Ann Oncol"},{"key":"2023010808101333500_bjd21670-bib-0004","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1470-2045(15)00083-2","article-title":"Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial","volume":"16","author":"Ribas","year":"2015","journal-title":"Lancet Oncol"},{"key":"2023010808101333500_bjd21670-bib-0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.21.02229","article-title":"Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma","volume":"40","author":"Wolchok","year":"2022","journal-title":"J Clin Oncol"},{"key":"2023010808101333500_bjd21670-bib-0006","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1200\/JCO.21.02549","article-title":"CheckMate-067: raising the bar for the next decade in oncology","volume":"40","author":"Weiss","year":"2022","journal-title":"J Clin Oncol"},{"key":"2023010808101333500_bjd21670-bib-0007","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO Guideline Update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"2023010808101333500_bjd21670-bib-0008","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00520-014-2577-5","article-title":"Variation in fatigue among 6011 (long-term) cancer survivors and a normative population: a study from the population-based PROFILES registry","volume":"23","author":"Husson","year":"2015","journal-title":"Support Care Cancer"},{"key":"2023010808101333500_bjd21670-bib-0009","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/cncr.31369","article-title":"Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES registry: prevalence, predictors, and impact on quality of life","volume":"124","author":"Mols","year":"2018","journal-title":"Cancer"},{"key":"2023010808101333500_bjd21670-bib-0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/pon.1204","article-title":"The impact of physical and psychosocial factors on work characteristics after cancer","volume":"17","author":"Steiner","year":"2008","journal-title":"Psychooncology"},{"key":"2023010808101333500_bjd21670-bib-0011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11764-018-0723-7","article-title":"Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors","volume":"13","author":"Pearce","year":"2019","journal-title":"J Cancer Surviv"},{"key":"2023010808101333500_bjd21670-bib-0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024450","article-title":"Complex challenges for patients with protracted incurable cancer: an ethnographic study in a comprehensive cancer centre in the Netherlands","volume":"9","author":"Buiting","year":"2019","journal-title":"BMJ Open"},{"key":"2023010808101333500_bjd21670-bib-0013","volume-title":"Lost in Transition. From Cancer Patient to Cancer Survivor","author":"Hewitt","year":"2005"},{"key":"2023010808101333500_bjd21670-bib-0014","author":"Health Council of the Netherlands"},{"key":"2023010808101333500_bjd21670-bib-0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0506","article-title":"Evaluation of factors associated with unmet needs in adult cancer survivors in Canada","volume":"3","author":"Shakeel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2023010808101333500_bjd21670-bib-0016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cancers13010100","article-title":"Perspectives of esophageal cancer survivors on diagnosis, treatment, and recovery","volume":"13","author":"Bennett","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2023010808101333500_bjd21670-bib-0017","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000260","article-title":"Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors","volume":"8","author":"Mamoor","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2023010808101333500_bjd21670-bib-0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116440","article-title":"Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study","volume":"10","author":"Beutel","year":"2015","journal-title":"PLOS ONE"},{"key":"2023010808101333500_bjd21670-bib-0019","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/bjd.19868","article-title":"Exploring the melanoma survivorship experience: a qualitative study","volume":"185","author":"Wolner","year":"2021","journal-title":"Br J Dermatol"},{"key":"2023010808101333500_bjd21670-bib-0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.311.6996.42","article-title":"Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research","volume":"311","author":"Pope","year":"1995","journal-title":"BMJ"},{"key":"2023010808101333500_bjd21670-bib-0021","first-page":"3","volume-title":"Qualitative Methods for Health Research","author":"Green","year":"2018","edition":"4th edn"},{"key":"2023010808101333500_bjd21670-bib-0022","first-page":"147","volume-title":"Qualitative Methods for Health Research","author":"Green","year":"2018","edition":"4th edn"},{"key":"2023010808101333500_bjd21670-bib-0023","first-page":"115","volume-title":"Qualitative Methods for Health Research","author":"Green","year":"2018","edition":"4th edn"},{"key":"2023010808101333500_bjd21670-bib-0024","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for Reporting Qualitative Research: a synthesis of recommendations","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"key":"2023010808101333500_bjd21670-bib-0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/jama.284.3.357","article-title":"Users\u2019 guides to the medical literature: XXIII. Qualitative research in health care A. Are the results of the study valid? Evidence-Based Medicine Working Group","volume":"284","author":"Giacomini","year":"2000","journal-title":"JAMA"},{"key":"2023010808101333500_bjd21670-bib-0026","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4135\/9781849209403","volume-title":"Keywords in Qualitative Methods","author":"Bloor","year":"2006"},{"key":"2023010808101333500_bjd21670-bib-0027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archdermatol.2010.433","article-title":"Impact of melanoma on patients\u2019 lives among 562 survivors: a Dutch population-based study","volume":"147","author":"Holterhues","year":"2011","journal-title":"Arch Dermatol"},{"key":"2023010808101333500_bjd21670-bib-0028","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejca.2016.07.018","article-title":"Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma","volume":"67","author":"Schadendorf","year":"2016","journal-title":"Eur J Cancer"},{"key":"2023010808101333500_bjd21670-bib-0029","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/pon.4290","article-title":"Systematic review of psychosocial outcomes for patients with advanced melanoma","volume":"26","author":"Dunn","year":"2017","journal-title":"Psychooncology"},{"key":"2023010808101333500_bjd21670-bib-0030","volume-title":"The Discovery of Grounded Theory: Strategies for Qualitative Research","author":"Glaser","year":"1967"},{"key":"2023010808101333500_bjd21670-bib-0031","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijnurstu.2011.09.012","article-title":"QUAGOL: a guide for qualitative data analysis","volume":"49","author":"Dierckx de Casterle","year":"2012","journal-title":"Int J Nurs Stud"},{"key":"2023010808101333500_bjd21670-bib-0032","first-page":"122","volume-title":"Analyseren in Kwalitatief Onderzoek","author":"Boeije","year":"2019","edition":"3rd edn"},{"key":"2023010808101333500_bjd21670-bib-0033","first-page":"114","volume-title":"The SAGE Encyclopedia of Qualitative Research Methods","author":"Constant comparison","year":"2008"},{"key":"2023010808101333500_bjd21670-bib-0034","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a288","article-title":"An introduction to reading and appraising qualitative research","volume":"337","author":"Kuper","year":"2008","journal-title":"BMJ"},{"key":"2023010808101333500_bjd21670-bib-0035","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/1049732316665344","article-title":"Code saturation versus meaning saturation: how many interviews are enough?","volume":"27","author":"Hennink","year":"2017","journal-title":"Qual Health Res"},{"key":"2023010808101333500_bjd21670-bib-0036","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00520-015-2796-4","article-title":"Late effects of cancer and cancer treatment \u2013 the perspective of the patient","volume":"24","author":"Treanor","year":"2016","journal-title":"Support Care Cancer"},{"key":"2023010808101333500_bjd21670-bib-0037","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1007\/s00520-019-05168-3","article-title":"Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study","volume":"28","author":"Rogiers","year":"2020","journal-title":"Support Care Cancer"},{"key":"2023010808101333500_bjd21670-bib-0038","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/0269216316647610","article-title":"How does uncertainty shape patient experience in advanced illness? A secondary analysis of qualitative data","volume":"31","author":"Etkind","year":"2017","journal-title":"Palliat Med"},{"key":"2023010808101333500_bjd21670-bib-0039","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s00520-018-4443-3","article-title":"Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy","volume":"27","author":"Levy","year":"2019","journal-title":"Support Care Cancer"},{"key":"2023010808101333500_bjd21670-bib-0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/sjop.12572","article-title":"\u2018It\u2019s been a life-changing experience!\u2019 A qualitative study of young adult cancer survivors\u2019 experiences of the coexistence of negative and positive outcomes after cancer treatment","volume":"60","author":"Hauken","year":"2019","journal-title":"Scand J Psychol"},{"key":"2023010808101333500_bjd21670-bib-0041","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/CMR.0000000000000059","article-title":"A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers","volume":"24","author":"Tan","year":"2014","journal-title":"Melanoma Res"},{"key":"2023010808101333500_bjd21670-bib-0042","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.3390\/cancers13122868","article-title":"Loss of paid employment up to 4 years after colorectal cancer diagnosis \u2013 a nationwide register-based study with a population-based reference group","volume":"13","author":"de Wind","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2023010808101333500_bjd21670-bib-0043","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1007\/s00520-020-05719-z","article-title":"Financial toxicity and employment status in cancer survivors. A systematic literature review","volume":"28","author":"Mols","year":"2020","journal-title":"Support Care Cancer"},{"key":"2023010808101333500_bjd21670-bib-0044","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3390\/cancers13102444","article-title":"Trajectories of cognitive symptoms in sick-listed cancer survivors","volume":"13","author":"Klaver","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2023010808101333500_bjd21670-bib-0045","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7326\/0003-4819-139-7-200310070-00009","article-title":"Innovations in access to care: a patient-centered approach","volume":"139","author":"Berry","year":"2003","journal-title":"Ann Intern Med"},{"key":"2023010808101333500_bjd21670-bib-0046","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.pec.2008.07.006","article-title":"Everyday use of patient-centred, motivational techniques in routine consultations between doctors and patients with diabetes","volume":"73","author":"Moran","year":"2008","journal-title":"Patient Educ Couns"},{"key":"2023010808101333500_bjd21670-bib-0047","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1634\/theoncologist.2019-0184","article-title":"Survivorship care plans in cancer: a meta-analysis and systematic review of care plan outcomes","volume":"25","author":"Hill","year":"2020","journal-title":"Oncologist"},{"key":"2023010808101333500_bjd21670-bib-0048","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.13498","article-title":"The psychosocial impact of living with mesothelioma: experiences and needs of patients and their carers regarding supportive care","volume":"30","author":"Prusak","year":"2021","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2023010808101333500_bjd21670-bib-0049","first-page":"683","article-title":"Empowerment in cancer patients: does peer support make a difference?","volume":"31","author":"Ziegler","year":"2022","journal-title":"A systematic review. Psychooncology"},{"issue":"1 Suppl","key":"2023010808101333500_bjd21670-bib-0050","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.apmr.2017.10.007","article-title":"Long-term social reintegration outcomes for burn survivors with and without peer support attendance: a Life Impact Burn Recovery Evaluation (LIBRE) study","volume":"101","author":"Grieve","year":"2020","journal-title":"Arch Phys Med Rehabil"},{"key":"2023010808101333500_bjd21670-bib-0051","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/jrc.2020.3","article-title":"How peer support can assist job-seekers with a disability move into work","volume":"26","author":"Dorstyn","year":"2020","journal-title":"Austr J Rehab Counsel"},{"key":"2023010808101333500_bjd21670-bib-0052","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00520-018-4197-y","article-title":"Survivorship care models for breast cancer, colorectal cancer, and adolescent and young adult (AYA) cancer survivors: a systematic review","volume":"26","author":"Ke","year":"2018","journal-title":"Support Care Cancer"},{"key":"2023010808101333500_bjd21670-bib-0053","volume-title":"Survivorship Care After Testicular Cancer: New Insights in Late Effects of Treatment and Approaches to Shared-Care Follow-Up","author":"Boer","year":"2019"},{"key":"2023010808101333500_bjd21670-bib-0054","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7748\/nr2005.01.12.3.32.c5946","article-title":"Telephone interviewing in healthcare research: a summary of the evidence","volume":"12","author":"Smith","year":"2005","journal-title":"Nurse Res"},{"key":"2023010808101333500_bjd21670-bib-0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1468794104041110","article-title":"Comparing telephone and face-to-face qualitative interviewing: a research note","volume":"4","author":"Sturges","year":"2004","journal-title":"Qual Res Psychol"},{"key":"2023010808101333500_bjd21670-bib-0056","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"2023010808101333500_bjd21670-bib-0057","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.21670","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.21670","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/187\/3\/381\/48528748\/bjd0381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/187\/3\/381\/48528748\/bjd0381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:13:15Z","timestamp":1676383995000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/187\/3\/381\/6966610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9,1]]},"published-print":{"date-parts":[[2022,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.21670","relation":{},"ISSN":["1365-2133","0007-0963"],"issn-type":[{"value":"1365-2133","type":"electronic"},{"value":"0007-0963","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,9,1]]},"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"2022-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}